Apolipoprotein AIV: A potent endogenous inhibitor of lipid oxidation

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 274, Issue 5 43-5, 1998, Pages

  Qin, Xiaofa ^a   Swertfeger, Debi K ^a   Zheng, Shuqin ^a   Hui, David Y ^a   Tso, Patrick ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Antioxidative activity; Atherosclerosis; Interstitial fluid; Lipoprotein oxidation; Lymph

Indexed keywords

ALKADIENE; APOLIPOPROTEIN A4; APOLIPOPROTEIN E; BOVINE SERUM ALBUMIN; LIPID; LOW DENSITY LIPOPROTEIN; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ANIMAL CELL; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; DOSE RESPONSE; INTERSTITIAL FLUID; INTESTINE LYMPH; LIPID OXIDATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0031805581     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.1998.274.5.h1836     Document Type: Article

References (22)

1. Chisolm, G. M., III, and M. S. Penn. Oxidized lipoproteins and atherosclerosis. In: Atherosclerosis and Coronary Artery Disease, edited by V. Fuster, R. Ross, and E. J. Topol. Philadelphia, PA: Lippincott-Raven, 1996, vol. 1, p. 129-149.
2. Cohen, R. D., L. W. Castellani, J. H. Qiao, B. J. V. Lenten, A. J. Lusis, and K. Reue. Reduced aortic lesions and elevated high density lipoprotein levels in transgenic mice overexpressing mouse apolipoprotein A-IV. J. Clin. Invest. 99: 1906-1916, 1997.
3. Dallinga-Thie, G. M., A. van Tol, F. M. van't Hooft, and P. H. Groot. Distribution of apolipoproteins A-I and A-IV among lipoprotein classes in rat mesenteric lymph, fractionated by molecular sieve chromatography. Biochim. Biophys. Acta 876: 108-115, 1986.
4. Duverger, N., G. Tremp, J. M. Caillaud, F. Emmanuel, G. Castro, J. C. Fruchart, A. Steinmetz, and P. Denefle. Protection against atherogenesis in mice mediated by human apolipoprotein AIV. Science 273: 966-968, 1996.
5. Dvorin, E., N. L. Gorder, D. M. Benson, and A. M. J. Gotto. Apolipoprotein A-IV. A determinant for binding and uptake of high density lipoproteins by rat hepatocytes. J. Biol. Chem. 261: 15714-15718, 1986.
6. Emmanuel, F., A. Steinmetz, M. Rosseneu, R. Brasseur, N. Gosselet, F. Attenot, S. Cuine, S. Seguret, M. Latta, J. C. Fruchart, and P. Denefle. Identification of specific amphipathic alpha-helical sequence of human apolipoprotein A-IV involved in lecithin:cholesterol acyltransferase activation. J. Biol. Chem. 269: 29883-29890, 1994.
7. Fujimoto, K., J. A. Cardelli, and P. Tso. Increased apolipoprotein A-IV in rat mesenteric lymph after lipid meal acts as a physiological signal for satiation. Am. J. Physiol. 262 (Gastrointest. Liver Physiol. 25): G1002-G1006, 1992.
8. Goldberg, I. J., C. A. Scheraldi, L. K. Yacoub, U. Saxena, and C. L. Bisgaier. Lipoprotein ApoC-II activation of lipoprotein lipase. Modulation by apolipoprotein A-IV. J. Biol. Chem. 265: 4266-4272, 1990.
9. Green, P. H., R. M. Glickman, J. W. Riley, and E. Quinet. Human apolipoprotein A-IV. Intestinal origin and distribution in plasma. J. Clin. Invest. 65: 911-919, 1980.
10. Havel, R. J., H. A. Eder, and J. H. Bragdon. Distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J. Clin. Invest. 34: 1345-1353, 1955.
11. Hayashi, H., D. F. Nutting, K. Fujimoto, J. A. Cardelli, D. Black, and P. Tso. Transport of lipid and apolipoproteins A-I and A-IV in intestinal lymph of the rat. J. Lipid Res. 31: 1613-1625, 1990.
12. Hulea, S. A., E. Waswicz, and F. A. Kummerow. Inhibition of metal-catalyzed oxidation of low-density lipoprotein by free and albumin-bound bilirubin. Biochim. Biophys. Acta 1259: 29-38, 1995.
13. Kalogeris, T. J., K. Fukagawa, and P. Tso. Synthesis and lymphatic transport of intestinal apolipoprotein A-IV in response to graded doses of triglyceride. J. Lipid Res. 35: 1141-1151, 1994.
14. Kleinveld, H. A., H. L. M. Hak-Lemmers, A. F. H. Stalenhoef, and P. N. M. Demacker. Improved measurement of low-density-lipoprotein susceptibility to copper-induced oxidation: application of a short procedure for isolating low-density lipoprotein. Clin. Chem. 38: 2066-2072, 1992.
15. Miyata, M., and J. D. Smith. Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidative insults and beta-amyloid peptides. Nat. Genet. 14: 55-61, 1996.
16. Miyata, Y., S. Koga, and H. Ibayashi. Alterations in plasma levels of apolipoprotein A-IV in various clinical entities. Gastroenterol. Jpn. 21: 479-485, 1986.
17. Palinski, W., V. A. Ord, A. S. Plump, J. L. Breslow, D. Steinberg, and J. L. Witztum. Apo E-deficient mice are a model of lipoprotein oxidation in atherogenesis. Arterioscler. Thromb. 14: 605-616, 1994.
18. Plump, A. S., C. J. Scott, and J. L. Breslow. Human apolipoprotein A-I gene expression increases high density lipoprotein and suppresses atherosclerosis in the apolipoprotein E-deficient mouse. Proc. Natl. Acad. Sci. USA 91: 9607-9611, 1994.
19. Sloop, S. H., L. Dory, B. R. Krause, C. Castle, and P. S. Roheim. Lipoproteins and apolipoproteins in peripheral lymph of normal and cholesterol-fed dogs. Arteriosclerosis 49: 91-21, 1983.
20. Stein, O., Y. Stein, M. Lefevre, and P. S. Roheim. The role of apolipoprotein A-IV in reverse cholesterol transport studied with cultured cells and liposomes derived from an ether analog of phosphatidylcholine. Biochim. Biophys. Acta 878: 7-13, 1986.
21. Steinberg, D., S. Parthasarathy, T. E. Carew, J. C. Khoo, and J. L. Witztum. Beyond cholesterol: modification of low-density lipoprotein that increase its atherogenicity. N. Engl. J. Med. 320: 915-923, 1989.
22. Tso, P., M. D. Karlstad, B. R. Bistrian, and S. J. DeMichele. Intestinal digestion, absorption, and transport of structured triglycerides and cholesterol in rats. Am. J. Physiol. 268 (Gastrointest. Liver Physiol. 31): G568-G577, 1995.